Celebrex and Coagulation time prolonged - a phase IV clinical study of FDA data

Summary:

Coagulation time prolonged is reported as a side effect among people who take Celebrex (celecoxib), especially for people who are male, 50-59 old, also take Vioxx, and have Analgesic effect.

The phase IV clinical study analyzes which people have Coagulation time prolonged when taking Celebrex. It is created by eHealthMe based on reports of 147,540 people who have side effects when taking Celebrex from the FDA, and is updated regularly.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,106 Celebrex users. Check the latest studies of Celebrex.

What is Coagulation time prolonged?

Coagulation time prolonged is found to be associated with 213 drugs and 404 conditions by eHealthMe. Check the latest studies of Coagulation time prolonged.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

147,540 people reported to have side effects when taking Celebrex.
Among them, 15 people (0.01%) have Coagulation time prolonged.

Could Celebrex cause Coagulation time prolonged?

Among these 15 people:

What is the gender of people who have Coagulation time prolonged when taking Celebrex? *

female: 26.67 %
male: 73.33 %

What is the age of people who have Coagulation time prolonged when taking Celebrex? *

What are other drugs people take besides Celebrex? *

What are other side effects people have besides Coagulation time prolonged? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 46.67%
Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 6 people, 40.00%
Cardiac Failure Congestive: 6 people, 40.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 5 people, 33.33%
Ventricular Extrasystoles (premature cardiac contraction): 4 people, 26.67%
Overdose: 4 people, 26.67%
Haemorrhage (bleeding): 4 people, 26.67%
Weight Decreased: 3 people, 20.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 20.00%
Gouty Arthritis (joint inflammation with crystal formation): 3 people, 20.00%

What are the existing conditions these people have? *

Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 20.00%
Joint Pain: 3 people, 20.00%
Analgesic Effect: 3 people, 20.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 13.33%
Diabetes: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Celebrex and have Coagulation time prolonged?

- Check whether Coagulation time prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celebrex:

Celebrex (151,106 reports)

Browse all side effects of Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Coagulation time prolonged:

Coagulation time prolonged (213 drugs)

Browse all the conditions that are associated with Coagulation time prolonged:

Coagulation time prolonged (404 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.